16May2016 Immuno-Oncology: Who’s Doing What? /Luke Timmerman/1/All, Cancer, Drugs16 May 2016 Please subscribe and tell your friends why it’s worthwhile. Quality journalism costs money. When you subscribe to Timmerman Report at $169 per year, you reward quality independent biotech reporting, and encourage more. Subscribe Now Sign in to your account.